# Ran Duan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ran-duan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 323 |
| Field | Diabetes Management and Research |
| h-index | 12 |
| i10-index | 13 |
| Last Known Institution | Shenyang Agricultural University |
| OpenAlex ID | https://openalex.org/A5043062497 |
| ORCID iD | 0000-0001-6896-252X |
| Works | 40 |

## Researcher papers

- [Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US](https://scholariq.org/papers/basal-insulin-persistence-associated-factors-and-outcomes-after-treatment/)
- [Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer](https://scholariq.org/papers/tumor-microenvironment-status-predicts-the-efficacy-of-postoperative/)
- [FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial](https://scholariq.org/papers/folfiri-folinic-acid-fluorouracil-and-irinotecan-increases-not-efficacy-but/)
- [Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial](https://scholariq.org/papers/patient-reported-outcomes-in-transition-from-high-dose-u-100-insulin-to-human/)
- [Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )](https://scholariq.org/papers/glycaemic-outcomes-of-an-scp-i-scp-ndividualized-treat-scp-m-scp-ent-a-scp-p-scp/)
- [Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study](https://scholariq.org/papers/comparison-of-efficacy-and-safety-of-two-starting-insulin-regimens-in-non-asian/)
- [Association between mild and severe hypoglycemia in people with type 2 diabetes initiating insulin](https://scholariq.org/papers/association-between-mild-and-severe-hypoglycemia-in-people-with-type-2-diabetes/)
- [Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database](https://scholariq.org/papers/risk-factors-for-nocturnal-hypoglycemia-in-insulin-treated-patients-with-type-2/)
- [Evaluating glucose‐lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial](https://scholariq.org/papers/evaluating-glucose-lowering-treatment-in-older-people-with-diabetes-lessons-from/)
- [Combined morphine and limb remote ischemic perconditioning provides an enhanced protection against myocardial ischemia/reperfusion injury by antiapoptosis](https://scholariq.org/papers/combined-morphine-and-limb-remote-ischemic-perconditioning-provides-an-enhanced/)
- [Initial ablation radio predicting volume reduction from microwave ablation of benign thyroid nodules](https://scholariq.org/papers/initial-ablation-radio-predicting-volume-reduction-from-microwave-ablation-of/)

## Researcher topics

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Statistical Methods and Inference](https://scholariq.org/topics/statistical-methods-and-inference/)

## Researcher university

- [Shenyang Agricultural University](https://scholariq.org/institutions/shenyang-agricultural-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
